Loading...
Broad spectrum efficacy with LY2969822, an oral prodrug of metabotropic glutamate 2/3 receptor agonist LY2934747, in rodent pain models
BACKGROUND AND PURPOSE: A body of evidence suggests activation of metabotropic glutamate 2/3 (mGlu(2/3)) receptors would be an effective analgesic in chronic pain conditions. Thus, the analgesic properties of a novel mGlu(2/3) receptor agonist prodrug were investigated. EXPERIMENTAL APPROACH: After...
Na minha lista:
| Udgivet i: | Br J Pharmacol |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5386998/ https://ncbi.nlm.nih.gov/pubmed/28177520 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13740 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|